Affiliations 

  • 1 Gleneagles Medical Centre, Penang, Malaysia. [email protected]
  • 2 Department of Surgery, University Malaya Medical Centre, Kuala Lumpur, Malaysia. [email protected]
  • 3 Department of Surgery, University Malaya Medical Centre, Kuala Lumpur, Malaysia. [email protected]
  • 4 Department of Biomedical Imaging, University Malaya Medical Centre, Kuala Lumpur, Malaysia. [email protected]
  • 5 Department of Biomedical Imaging, University Malaya Medical Centre, Kuala Lumpur, Malaysia. [email protected]
  • 6 Department of Biomedical Imaging, University Malaya Medical Centre, Kuala Lumpur, Malaysia. [email protected]
  • 7 Department of Surgery, University Malaya Medical Centre, Kuala Lumpur, Malaysia. [email protected]
  • 8 Department of Surgery, University Malaya Medical Centre, Kuala Lumpur, Malaysia. [email protected]
  • 9 Department of Surgery, University Malaya Medical Centre, Kuala Lumpur, Malaysia. [email protected]
BMC Cancer, 2015;15:405.
PMID: 25972043 DOI: 10.1186/s12885-015-1419-2

Abstract

Breast cancer is the leading cause of cancer deaths in women world-wide. In low and middle income countries, where there are no population-based mammographic screening programmes, late presentation is common, and because of inadequate access to optimal treatment, survival rates are poor. Mammographic screening is well-studied in high-income countries in western populations, and because it has been shown to reduce breast cancer mortality, it has become part of the healthcare systems in such countries. However the performance of mammographic screening in a developing country is largely unknown. This study aims to evaluate the performance of mammographic screening in Malaysia, a middle income country, and to compare the stage and surgical treatment of screen-detected and symptomatic breast cancer.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.